Equities

EBOS Group Ltd

EBOS Group Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)39.16
  • Today's Change0.40 / 1.03%
  • Shares traded1.52k
  • 1 Year change+5.81%
  • Beta--
Data delayed at least 20 minutes, as of Feb 01 2023 23:20 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • EBO:ASX price moved over -1.06% to 40.88
  • EBO:ASX trading volume exceeds daily average by +15.03%
  • EBO:ASX price falls below 50-day moving average to 40.03 at 12:03 GMT

Key statistics

As of last trade EBOS Group Ltd (EBO:ASX) traded at 39.16, -14.44% below its 52-week high of 45.77, set on Jan 17, 2023.
52-week range
Today
31.10Oct 13 202245.77Jan 17 2023
Markit short selling activity
Low
Med
High
Open39.16
High39.16
Low39.15
Bid39.06
Offer39.16
Previous close38.76
Average volume16.93k
Shares outstanding190.64m
Free float155.99m
P/E (TTM)34.26
Market cap8.50bn NZD
EPS (TTM)1.26
NZD
Annual div (ADY)0.9447
AUD
Annual div yield (ADY)2.16%
Div ex-dateSep 08 2022
Div pay-dateSep 30 2022
Data delayed at least 20 minutes, as of Feb 01 2023 23:20 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.